Who owns DMRA? 13F holders and whale ownership
DMRA is tracked across public portfolios in Whale Analyzer. This page answers who owns DMRA, which top funds are buying DMRA, aggregate disclosed value, and recent position changes based on public data.
Open interactive stock dashboardTop holders
| Investor | Reported value | Shares | Change |
|---|---|---|---|
| Peter Kolchinsky 13F portfolio RA Capital Management holdings | $62.1M | 2.4M | New |
| Andreas Halvorsen 13F portfolio Viking Global Investors holdings | $59.9M | 2.3M | New |
| Joseph Edelman 13F portfolio Perceptive Advisors holdings | $31.7M | 1.2M | New |
How to read this page
Values are reported public positions from tracked investors and institutions. They are not real-time ownership totals for the company.
Related stock holder pages
- ASND whale holders — ASCENDIS PHARMA A/S - ADR
- PCVX whale holders — VAXCYTE INC
- RYTM whale holders — RHYTHM PHARMACEUTICALS INC
- TYRA whale holders — TYRA BIOSCIENCES INC
- SION whale holders — SIONNA THERAPEUTICS INC
- EWTX whale holders — EDGEWISE THERAPEUTICS INC
- NAMSW whale holders — NEWAMSTERDAM PHARMA CO NV
- NUVL whale holders — NUVALENT INC-A
Learn more in Whale Analyzer Academy
Frequently asked questions
Who owns DMRA stock?
Whale Analyzer tracks 3 public institutional holders of DMRA with a combined reported value of $153.7M. See the holder table above for the largest tracked positions.
Which top funds are buying DMRA?
Check the "Change" column in the holders table above. "New" means a fresh position was initiated, "Added" means an existing position was increased, and "Reduced" or "Sold" indicates trimming.
What does 13F ownership mean for DMRA?
Use the interactive DMRA dashboard on Whale Analyzer for real-time holder analysis, or read our 13F Alpha Signals Guide.